Moderna is trading at $144.39 (+5.69%) as broad U.S. markets rally after August inflation matched expectations.
- Broad market rally followed 3.4% August CPI, matching forecasts.
- The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are each up more than 1%, supporting a market-wide risk-on move.
- No new company-specific catalyst was identified in September 11 coverage; earlier cancer-vaccine and flu-vaccine news does not clearly explain this move.